» Articles » PMID: 31777350

Albinism: Epidemiology, Genetics, Cutaneous Characterization, Psychosocial Factors

Overview
Specialty Dermatology
Date 2019 Nov 29
PMID 31777350
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Oculocutaneous albinism is an autosomal recessive disease caused by the complete absence or decrease of melanin biosynthesis in melanocytes. Due to the reduction or absence of melanin, albinos are highly susceptible to the harmful effects of ultraviolet radiation and are at increased risk of actinic damage and skin cancer. In Brazil, as in other parts of the world, albinism remains a little known disorder, both in relation to epidemiological data and to phenotypic and genotypic variation. In several regions of the country, individuals with albinism have no access to resources or specialized medical care, and are often neglected and deprived of social inclusion. Brazil is a tropical country, with a high incidence of solar radiation during the year nationwide. Consequently, actinic damage and skin cancer occur early and have a high incidence in this population, often leading to premature death. Skin monitoring of these patients and immediate therapeutic interventions have a positive impact in reducing the morbidity and mortality associated with this condition. Health education is important to inform albinos and their families, the general population, educators, medical professionals, and public agencies about the particularities of this genetic condition. The aim of this article is to present a review of the epidemiological, clinical, genetic, and psychosocial characteristics of albinism, with a focus in skin changes caused by this rare pigmentation disorder.

Citing Articles

The small molecule ML233 is a direct inhibitor of tyrosinase function.

Menard R, Baanannou A, Halluin C, Morse D, Kuhn S, Graber J bioRxiv. 2025; .

PMID: 40027619 PMC: 11870624. DOI: 10.1101/2025.02.16.638443.


"Exploring the intersection of albinism and Trichilemmal carcinoma: A case of bilateral trichilemmal carcinoma in the axilla".

Dfallah M, Elamin A, Gerib M, Ahmed K, Arabi A, Mutwali O Int J Surg Case Rep. 2025; 128:110926.

PMID: 39961174 PMC: 11875828. DOI: 10.1016/j.ijscr.2025.110926.


The importance of genetic counselling and testing in inherited eye diseases: A population-based retrospective study.

Kaminer Abargel M, Macarov M, Hendler K, Yahalom C PLoS One. 2025; 20(2):e0318492.

PMID: 39946424 PMC: 11825002. DOI: 10.1371/journal.pone.0318492.


Albinism and Blood Cell Profile: The Peculiar Case of Asinara Donkeys.

Cappai M, Senes A, Pilo G Animals (Basel). 2024; 14(18).

PMID: 39335231 PMC: 11429210. DOI: 10.3390/ani14182641.


Clinical and Genetic Correlation in Neurocristopathies: Bridging a Precision Medicine Gap.

Chatzi D, Kyriakoudi S, Dermitzakis I, Manthou M, Meditskou S, Theotokis P J Clin Med. 2024; 13(8).

PMID: 38673496 PMC: 11050951. DOI: 10.3390/jcm13082223.


References
1.
Oh J, Ho L, Ala-Mello S, Amato D, Armstrong L, Bellucci S . Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. Am J Hum Genet. 1998; 62(3):593-8. PMC: 1376951. DOI: 10.1086/301757. View

2.
Lenzi T, Reis C, Novaes M . Epidemiological profile of elderly patients with non-melanoma skin cancer seen at the dermatology outpatient clinic of a public hospital. An Bras Dermatol. 2018; 92(6):882-884. PMC: 5786415. DOI: 10.1590/abd1806-4841.20175701. View

3.
Eisemann N, Waldmann A, Geller A, Weinstock M, Volkmer B, Greinert R . Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol. 2013; 134(1):43-50. DOI: 10.1038/jid.2013.304. View

4.
Inagaki K, Suzuki T, Shimizu H, Ishii N, Umezawa Y, Tada J . Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan. Am J Hum Genet. 2004; 74(3):466-71. PMC: 1182260. DOI: 10.1086/382195. View

5.
Gronskov K, Ek J, Brondum-Nielsen K . Oculocutaneous albinism. Orphanet J Rare Dis. 2007; 2:43. PMC: 2211462. DOI: 10.1186/1750-1172-2-43. View